Compare IDXX & TTWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDXX | TTWO |
|---|---|---|
| Founded | 1983 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.1B | 43.2B |
| IPO Year | 1991 | 1997 |
| Metric | IDXX | TTWO |
|---|---|---|
| Price | $713.59 | $247.89 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 20 |
| Target Price | ★ $683.89 | $265.40 |
| AVG Volume (30 Days) | 593.8K | ★ 1.7M |
| Earning Date | 11-03-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.65 | N/A |
| EPS | ★ 12.60 | N/A |
| Revenue | $4,167,411,000.00 | ★ $6,219,900,000.00 |
| Revenue This Year | $12.15 | $17.42 |
| Revenue Next Year | $8.79 | $38.29 |
| P/E Ratio | $56.67 | ★ N/A |
| Revenue Growth | 8.39 | ★ 13.98 |
| 52 Week Low | $356.14 | $177.35 |
| 52 Week High | $769.98 | $264.79 |
| Indicator | IDXX | TTWO |
|---|---|---|
| Relative Strength Index (RSI) | 52.39 | 54.06 |
| Support Level | $722.29 | $242.19 |
| Resistance Level | $739.15 | $250.00 |
| Average True Range (ATR) | 21.85 | 5.24 |
| MACD | -3.27 | 1.43 |
| Stochastic Oscillator | 46.16 | 82.62 |
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
Take-Two is one of the largest global developers and publishers of video games, with labels including Rockstar, 2K, and Zynga. Grand Theft Auto is the firm's biggest franchise, accounting for about 30% of total sales for the past decade. NBA 2K is the industry's dominant basketball video game, with Take-Two releasing a new version annually. Other notable franchises include Red Dead Redemption, Borderlands, and Civilization. Typically, more than three-fourths of the firm's sales are from in-game spending, with the remainder coming from initial game sales. Since acquiring Zynga in 2022, mobile makes up about half of total sales.